Clinical Trial Update: Colistin Versus Colistin Plus Fosfomycin for Infections Caused by MDR Acinetobacter Baumannii [Phase 3]

View source ↗

Summary

This clinical trial update discusses a Phase 3 study comparing colistin alone versus colistin plus fosfomycin for infections caused by multidrug-resistant Acine…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acinetobacter Baumannii Infection

Drugs mentioned

• Colistin (colistin)
• Fosfomycin (Fosfomycin)

Snippet

Sponsor: Mahidol University | Conditions: Drug Safety | Phase 3 | Status: UNKNOWN